Fig. 1From: Nebulised surface-active hybrid nanoparticles of voriconazole for pulmonary Aspergillosis demonstrate clathrin-mediated cellular uptake, improved antifungal efficacy and lung retentionFESEM images of a Voriconazole at 6 K, b Chitosan nanoparticles at 60X (inset laser diffraction histogram), c Lipid-polymer hybrid nanoparticles at 60X (inset laser diffraction histogram) and d lipid-polymer hybrid nanoparticles at 120X; PXRD spectra of e Voriconazole, f physical mixture of drug and excipients, g Chitosan nanoparticles and h lipid-polymer hybrid nanoparticlesBack to article page